#Denmark #Copenhagen #Hedia #Rasmus Kofoed #Diabetes Tech

Leadership Change at Hedia

Hedia, a leading Danish company specializing in diabetes technology, is set to undergo a significant leadership transition as Rasmus Kofoed takes the reins as Chief Executive Officer (CEO) from Lars Christian Lund, effective December 1, 2025. This pivotal change marks a new chapter in Hedia’s journey within the digital health sector.

Lars Christian Lund, who has been at the helm for nearly two years, has decided to leave his position to take on a role as Group CEO in another international firm. Under Lund's guidance, Hedia has evolved from a promising startup to a robust player in the market, achieving crucial regulatory approvals and solidifying its commercial presence.

The announcement was made by Carl Bilbo, Chairman of the Board, who emphasized the remarkable journey and growth Hedia has experienced under Lund. “Lars has played a central role in strengthening the organization, securing MDR approval, and building the foundation for global growth,” said Bilbo. He also extended gratitude to Lund for his dedication and contributions, while expressing enthusiasm for Kofoed's appointment.

Rasmus Kofoed brings a wealth of experience to his new role, having held senior leadership positions at notable companies in the life sciences and medical technology fields, including Novo Nordisk, Abbott, Roche, and Medtronic. His previous role as CEO of ChemoMetec solidified his expertise in strategic growth and international expansion, both of which will be crucial as Hedia aims to broaden its horizons further.

“I see enormous potential in Hedia,” Kofoed shared in a statement. “The company combines clinical insight with technology in a way that creates real value for people with diabetes. I look forward to working with the team to extend our reach, strengthen our partnerships, and continue the journey to make Hedia a leading player in digital diabetes care.”

Hedia, established in 2016, has carved a niche in developing user-friendly digital solutions enabling people with insulin-dependent diabetes to better understand and manage their treatment. The company's innovative platform utilizes data analytics and artificial intelligence to empower users, making diabetes management more accessible and effective.

Under Kofoed's leadership, Hedia aims to fortify its product line and enhance its international collaborations, which will be vital for sustaining its competitive edge in the rapidly advancing digital health landscape. Kofoed's commitment to innovation and growth is expected to further escalate Hedia's reputation as a top-tier player in digital diabetes management.

As this leadership transition takes place, Hedia continues to affirm its dedication to expanding its international presence and enhancing its commercial engagement strategies. The industry will be closely watching as Rasmus Kofoed leads the company into this exciting new phase, armed with a clear vision and an ambitious roadmap for future success.

For more information on Hedia and its innovative solutions, visit Hedia's website.